SOURCE: IDenta Corp.

May 12, 2008 09:40 ET

International Drug & Explosives Detection Firm IDenta Releases One Year Review of Jant Pharmacal-Accutest Partnership

JERUSALEM--(Marketwire - May 12, 2008) - IDenta Corp. (PINKSHEETS: IDTA) today released a review of the first complete year of its U.S. partnership with Jant Pharmacal-Accutest. The report details numerous marketing activities that the two companies, www.AccutestIDenta.net, have jointly undertaken over the past year, specifically referencing a rapidly increasing U.S. law enforcement and safety industry customer base that has been converting to the use of drug and explosive detection products manufactured by IDenta.

"This one year anniversary of the IDenta - Jant Pharmacal partnership agreement may well be the most important turning point in our company's history," announced IDTA CEO Yaacov Shoham. "For several years we had been attempting to develop a dependable and competent network of representatives to move our product lines into the U.S. and Canadian marketplaces. The Jant Pharmacal-Accutest partnership was the answer we'd been searching for. Every member of this outstanding organization has contributed to making this partnership successful, but I especially wish to thank Mr. Eyal Golan for his diligence in making sure communications between our companies have stayed on the track of improvement."

"During the first quarter of 2008 the sales of Accutest IDenta have increased significantly," reported Eyal Golan, COO of Jant Pharmacal. "Over 100 law enforcement agencies have now started purchasing Accutest IDenta drug detection kits and/or IDenta explosive detection kits. These agencies include drug enforcement agencies, police departments, bomb squads, SWAT teams, fire departments, etc. throughout the United States."

Over the past year Jant Pharmacal Corporation and IDenta have entered into numerous business relationships to market the Accutest IDenta Drugs and Explosives Identification field test kit throughout the United States and Canada. Some of these activities have included:

1. With over 30 sales company representatives, Jant Pharmacal has achieved significant market penetration for the Accutest IDenta product line through penetration into regional and national law enforcement distributors, including the largest law enforcement product distributor in the U.S. Introduction of the product line to the Safety marketplace has also expanded product distribution.

2. Over the past three months the Accutest IDenta product line had been demonstrated and promoted at numerous specialized law enforcement, military and public safety national and regional tradeshows including Trexpo West, Colorado Sheriffs Show, Illinois Drug Enforcement Officers Association, The Oklahoma Sheriffs and Peace Officers, Texas Police Officers Association conference, The National Defense Industrial Association, and the Utah Sheriffs Show.

3. Accutest-IDenta products are being advertised and promoted in major law enforcement trade journals including The Law Enforcement Technology Magazine, Law Officer Magazine, American Probation and Parole, and the NarcOfficer magazine.

4. Jant has just launched the marketing of the Accutest IDenta BTK (bulleot hole detection kit) http://www.accutest.net/products/bullet-hole-test-kit.php. This unique product will be promoted to law enforcement, military and public safety distribution channels during the 2nd quarter of 2008.

5. Jant Pharmacal has received recently an official letter from the Commweatlth of Virginia laboratory which will enable Accutest and its representatives to make sales in Virginia and the law enforcement agencies neighboring states.

6. The Accutest IDenta Drug Identification Training Program has been a great asset for introducing the entire line of drug and explosive detection products to the network of safety and law enforcement reps, and has aided in the procurement of both distributors and product end-users.

"We are now confident that Identa has the necessary organizational alliances in place in the United States, and other countries internationally to achieve this year's sales goals," Shoham concluded.

On another matter outside of the Accutest review, IDenta also issued a brief statement concerning advanced business discussions with an unnamed top Fortune 500 company saying the two companies continue to discuss the potential use of IDenta drug and explosive detectors as a complement to the company's own product line. IDenta believes that these discussions have the potential to lead to a notable and substantial sales agreement at some point in the next six months.

ABOUT IDENTA

Since 2003, IDenta Corporation has become recognized as a world-wide leader in the development of proprietary on-site drug and explosive detection kits. IDenta develops, manufactures and distributes products for the both professional and civil markets which consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world. Information concerning IDenta's entire product line may be found at www.IDenta.biz

DISCLAIMER

Certain of the statements contained herein may be, within the meaning of the federal securities laws, "forward-looking statements" that are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. These forward-looking statements are based on management's expectations as of the date hereof, and the company does not undertake any responsibility to update any of these statements in the future.

Contact Information

  • For Investor Relations, lobbying interests or information concerning
    IDenta's products internationally, contact:
    Yaacov Shoham
    IDenta Corp.
    CEO
    Tel: +972-52-6554487
    fpi@drugsdetector.com

    For Investor Relations in the US, contact:
    Randy Jacobs
    Corporate Spokesman
    IDentaNews@sitcomllc.com
    1-800-316-9437

    For information about the Accutest® - IDenta products in the US, please
    contact:
    Mr. Eyal Golan
    COO
    JANT PHARMACAL CORPORATION
    16255 Ventura Blvd. #505
    Encino, CA 91436
    Toll Free: 800-676-5565
    http://www.accutest.net